Loading institutional data...
Loading institutional data...
Held by 396 of 5,944 reporting institutions (96th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash conversion lags reported earnings — watch accruals. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
Free-cash-flow coverage unavailable. Last year: $29M dividends + $0 buybacks = $29M returned on -$285M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: 2%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $147M is below the $304M due within a year — relies on refinancing or operating cash flow. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~5.3% on $2.7B of debt.
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $989.5M 100.0% | $879.7M 100.0% | $829.4M 100.0% | $734.2M 100.0% | $663.1M 100.0% | $705.3M 100.0% | $746.0M 100.0% | $719.3M 100.0% | $692.8M 100.0% | $662.6M 100.0% |
| Cost of Revenue | $716.9M 72.4% | $607.0M 69.0% | $565.4M 68.2% | $465.3M 63.4% | $398.7M 60.1% | $429.1M 60.8% | $476.7M 63.9% | $448.8M 62.4% | $424.4M 61.3% | $391.8M 59.1% |
| Cost of Products | — | — | — | — | — | — | — | — | $152.1M 22.0% | $130.2M 19.7% |
| Gross Profit | $272.7M 27.6% | $272.6M 31.0% | $264.0M 31.8% | $268.8M 36.6% | $264.3M 39.9% | $276.3M 39.2% | $269.3M 36.1% | $270.4M 37.6% | $268.5M 38.7% | $270.8M 40.9% |
| Research & Development | $6.3M 0.6% | $6.5M 0.7% | $7.2M 0.9% | $5.1M 0.7% | $4.1M 0.6% | $5.4M 0.8% | $4.6M 0.6% | $4.2M 0.6% | $3.2M 0.5% | $2.8M 0.4% |
| Selling, General & Admin | $79.6M 8.0% | $80.1M 9.1% | $68.2M 8.2% | $61.3M 8.3% | $75.9M 11.4% | $60.2M 8.5% | $55.8M 7.5% | $47.8M 6.6% | $42.9M 6.2% | $46.7M 7.0% |
| Operating Income | $169.2M 17.1% | $172.5M 19.6% | $166.6M 20.1% | $152.8M 20.8% | $169.4M 25.5% | $214.0M 30.3% | $193.8M 26.0% | $185.1M 25.7% | $205.0M 29.6% | $201.9M 30.5% |
| Interest Expense | $141.9M 14.3% | $134.0M 15.2% | $98.9M 11.9% | $87.7M 12.0% | $82.7M 12.5% | $78.0M 11.1% | $80.4M 10.8% | $70.9M 9.9% | $54.1M 7.8% | $67.4M 10.2% |
| Interest & Investment Income | $6.0M 0.6% | $7.9M 0.9% | $12.0M 1.4% | $3.4M 0.5% | $2.1M 0.3% | $1.7M 0.2% | $1.5M 0.2% | $974K 0.1% | $988K 0.1% | $971K 0.1% |
| Other Income (Expense), net | $385K 0.0% | $188K 0.0% | $1.5M 0.2% | -$709K -0.1% | -$134K -0.0% | $1.4M 0.2% | $880K 0.1% | $7.8M 1.1% | -$1.7M -0.2% | -$5.3M -0.8% |
| Pretax Income | $105.7M 10.7% | $115.4M 13.1% | $139.1M 16.8% | $95.6M 13.0% | $103.6M 15.6% | $168.7M 23.9% | $137.3M 18.4% | $137.2M 19.1% | $170.7M 24.6% | $141.1M 21.3% |
| Income Tax Expense | -$20.3M -2.0% | -$16.3M -1.9% | $6.0M 0.7% | $14.7M 2.0% | $24.9M 3.7% | $67.0M 9.5% | $45.6M 6.1% | $34.7M 4.8% | $21.7M 3.1% | $37.1M 5.6% |
| Net Income | $127.0M 12.8% | $131.2M 14.9% | $133.1M 16.1% | $77.8M 10.6% | $76.1M 11.5% | $85.5M 12.1% | $88.1M 11.8% | $98.0M 13.6% | $132.4M 19.1% | $88.7M 13.4% |
| Per Share | ||||||||||
| EPS (Basic) | $2.04 | $2.05 | $2.09 | $1.17 | $1.11 | $1.66 | $1.73 | $1.93 | $2.64 | $1.79 |
| EPS (Diluted) | $2.02 | $2.04 | $2.08 | $1.17 | $1.10 | $1.65 | $1.72 | $1.92 | $2.61 | $1.77 |
| Weighted Avg Shares (Basic) | 60.7M | 60.5M | 59.4M | 56.1M | 56.0M | 51.6M | 50.9M | 50.6M | 50.1M | 49.5M |
| Weighted Avg Shares (Diluted) | 61.4M | 60.8M | 59.8M | 56.5M | 56.4M | 51.9M | 51.2M | 51.0M | 50.8M | 50.1M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
EOD close · as of 2026-09-17
No standout strengths flagged.
Where each multiple sits in its own 14-yr range · 67th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 62.4 | 63.9 | 60.8 | 60.1 | 63.4 | 68.2 | 69.0 | 72.4 |
| Gross Profit | 37.6 | 36.1 | 39.2 | 39.9 | 36.6 | 31.8 | 31.0 | 27.6 |
| R&D | 0.6 | 0.6 | 0.8 | 0.6 | 0.7 | 0.9 | 0.7 | 0.6 |
| SG&A | 6.6 | 7.5 | 8.5 | 11.4 | 8.3 | 8.2 | 9.1 | 8.0 |
| Operating Income | 25.7 | 26.0 | 30.3 | 25.5 | 20.8 | 20.1 | 19.6 | 17.1 |
| Income Tax | 4.8 | 6.1 | 9.5 | 3.7 | 2.0 | 0.7 | -1.9 | -2.0 |
| Net Income | 13.6 | 11.8 | 12.1 | 11.5 | 10.6 | 16.1 | 14.9 | 12.8 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on ORA: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 95 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GEV | $249.3B | 52.3× | 124.5× | 6.5× | 9.0% | 19.8% | 12.8% | 43.7% | 43.4% | 0.0× | 2,989 |
| NEE | $167.4B | 24.4× | — | 6.5× | 9.8% | — | 26.5% | 12.5% | 4.6% | — | 2,911 |
| SO | $95.1B | 22.0× | — | 3.2× | 10.6% | — | 14.7% | 12.1% | 11.8% | — | 2,268 |
| DUK | $91.6B | 18.7× | 10.7× | 2.9× | 5.6% | — | 15.7% | 9.6% | 3.7% | 5.1× | 2,360 |
| CEG | $81.0B | 35.1× | 21.3× | 3.2× | 8.3% | — | 9.1% | 16.0% | 9.9% | 2.2× | 1,836 |
| AEP | $65.3B | 18.1× | 12.8× | 3.0× | 10.9% | — | 16.9% | 11.9% | 4.8% | 5.3× | 1,854 |
| D | $55.8B | 18.4× | — | 3.4× | 14.2% | — | 18.2% | 10.3% | 3.8% | — | 1,421 |
| SRE | $53.3B | 29.7× | — | 3.9× | 3.9% | — | 13.4% | 5.8% | 5.1% | — | 1,217 |
| VST | $47.5B | 64.4× | 16.8× | 2.7× | 3.0% | — | 5.3% | 18.5% | 3.9% | 4.8× | 1,246 |
| XEL | $45.3B | 21.3× | — | — | — | — | — | 8.5% | 3.5% | — | 1,208 |
| ETR | $45.2B | 26.2× | 13.1× | 3.5× | 9.0% | — | 13.7% | 10.5% | 3.9% | 5.2× | 1,224 |
| EXC | $43.4B | — | 11.1× | 1.8× | 5.3% | — | 11.4% | 9.6% | 3.6% | 5.9× | 1,230 |
| ED | $38.1B | 18.7× | — | 2.3× | 10.9% | — | 12.0% | 8.4% | 4.0% | — | 1,368 |
| PEG | $35.1B | 16.7× | — | 2.9× | 18.3% | — | 17.3% | 12.4% | 5.3% | — | 1,231 |
| WEC | $33.6B | 21.5× | 14.5× | 3.4× | 14.0% | 66.7% | 15.9% | 11.1% | 4.5% | 5.5× | 1,310 |
| AEE | $28.5B | 19.3× | — | 3.2× | 15.4% | — | 16.6% | 10.9% | 4.5% | — | 884 |
| AWK | $26.9B | 24.2× | 10.2× | 5.3× | 10.1% | — | 21.7% | 10.3% | 8.9% | 0.6× | 1,100 |
| FE | $26.2B | 25.8× | 6.8× | 1.7× | 12.0% | — | 6.8% | 8.2% | 7.9% | 0.1× | 894 |
| ATO | $26.2B | 21.7× | 11.3× | 5.6× | 12.9% | — | 25.5% | 8.8% | 8.8% | — | 961 |
| ES | $25.5B | 14.9× | 9.9× | 1.9× | 13.8% | — | 12.5% | 10.5% | 3.8% | 5.2× | 1,012 |
| PPL | $25.1B | 21.0× | 12.3× | 2.8× | 6.9% | — | 13.1% | 7.9% | 3.5% | 5.4× | 947 |
| CNP | $25.0B | 24.0× | 12.7× | 2.7× | 8.3% | 100.0% | 11.2% | 9.4% | 3.3% | 5.8× | 774 |
| EIX | $21.1B | 4.8× | 5.8× | 1.1× | 9.8% | — | 23.1% | 25.4% | 8.0% | 3.7× | 1,005 |
| NRG | $20.4B | 26.8× | 9.9× | 0.7× | 9.2% | — | 2.8% | 51.4% | 4.8% | 5.1× | 1,010 |
| CMS | $20.2B | 18.7× | 12.7× | 2.4× | 13.6% | — | 12.5% | 11.7% | 3.8% | 6.2× | 762 |
| ORA | $5.6B | 45.5× | 17.6× | 5.7× | 12.5% | 27.6% | 12.5% | 4.9% | 2.4% | 5.8× | 396 |
Peers = companies sharing ORA's sector (Utilities) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.